To accomplish this, we measured the messenger RNA (mRNA) and protein expression levels of GBP1 in the glioblastoma cell line U87 (termed U87-parental), and U87 cells engineered with EGFRvIII and kinase dead mutant (DK, as a negative control) by retrovirus transduction (termed U87-EGFRvIII and U87-DK, respectively). The gene discussed is GBP1; the disease is glioblastoma.